Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2020
Risk factors of impairment of shoulder function after axillary dissection for breast cancerMasato Kikuuchi, Yoshiteru Akezaki, Eiji Nakata, et al.
BMC Cancer|October 6, 2021
Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancerFumine Tsukamoto, Koji Arihiro, Mina Takahashi, et al.
Cancer|January 19, 2012
Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic IndexMakoto Ishitobi, Shozo Ohsumi, Hideo Inaji, et al.
Breast Cancer (Tokyo, Japan)|April 17, 2023
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE RegistryShozo Ohsumi, Kenichi Watanabe, Naoto Kondo, et al.
Clinical and Experimental Medicine|October 31, 2023
Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational studyShogo Nakamoto, Tadahiko Shien, Mitsuya Itoh, et al.
Japanese Journal of Clinical Oncology|May 29, 2020
Factors affecting enrollment in randomized controlled trials conducted for patients with metastatic breast cancerShozo Ohsumi, Hirofumi Mukai, Masato Takahashi, et al.
Japanese Journal of Clinical Oncology|June 24, 2022
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)Shigehira Saji, Shozo Ohsumi, Mitsuya Ito, et al.
Breast Cancer (Tokyo, Japan)|September 5, 2003
Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in JapanTakahiro Okamoto, Kojiro Shimozuma, Noriyuki Katsumata, et al.
Acta Medica Okayama|December 22, 2022
Handling of Germline Findings in Clinical Comprehensive Cancer Genomic ProfilingMika Okazawa-Sakai, Yasuko Yamamoto, Mashu Futagawa, et al.
Breast Cancer Research and Treatment|May 30, 2013
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancerHiroji Iwata, Norikazu Masuda, Shinji Ohno, et al.
Pageof 13